Ziming Li

机构：Beijing University of Posts and Telecommunications, Harbin Medical University, Shanghai Chest Hospital, Third Affiliated Hospital of Harbin Medical University, Hubei Polytechnic University, Beihang University · ORCID：0009-0004-7529-7176

发表论文 146 篇 · 总被引 1714 次 · h-index 23

代表论文

• D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial (2025 · Nature Medicine · 被引 21)
• Exploring Large Language Model-Driven Agents for Environment-Aware Spatial Interactions and Conversations in Virtual Reality Role-Play Scenarios (2025 · 被引 18)
• Advances in the Study of Age-Related Macular Degeneration Based on Cell or Cell-Biomaterial Scaffolds (2025 · Bioengineering · 被引 7)
• BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancer (2025 · Journal for ImmunoTherapy of Cancer · 被引 6)
• Development of 9H-purine scaffold as novel CDK2 inhibitors: Design, synthesis, and biological evaluation (2025 · Bioorganic & Medicinal Chemistry Letters · 被引 6)
• Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study (2025 · European Journal of Cancer · 被引 5)